Infoscience

Patent

Method for raising hdl cholesterol levels

Compounds which are PPAR delta agonists are described. These compounds are useful for raising high density lipoprotein (HDL) plasma levels in mammals and for preventing, halting or slowing the progression of atherosclerotic cardiovascular diseases and related conditions and disease events. PPAR delta agonists can be administered alone or in combination with additional active agents such as LDL-lowering agents

    Note:

    Applicant(s): Merck & Co Inc [Us], Leibowitz Mark D, Berger Joel P, Moller David E, Auwerx Johan, Berger Gregory D

    Reference

    Record created on 2009-04-21, modified on 2016-08-08

Fulltext

  • There is no available fulltext. Please contact the lab or the authors.

Related material